– Use and dissemination of foreground Clause Samples

– Use and dissemination of foreground. 1. The beneficiaries shall use the foreground which they own or ensure that it is used. 2. Each beneficiary shall ensure that the foreground which it owns is disseminated as swiftly as possible. If it fails to do so, the Commission may disseminate that foreground. 3. Dissemination activities shall be compatible with the protection of intellectual property rights, confidentiality obligations and the legitimate interests of the owner(s) of the foreground. 4. At least 45 days prior notice of any dissemination activity shall be given to the other beneficiaries concerned, including sufficient information concerning the envisaged dissemination activity and the data to be disseminated. Following notification, any of those beneficiaries may object to the envisaged dissemination activity within 30 days of notification if it considers that its legitimate interests in relation to its foreground could suffer disproportionately great harm. In such cases, the dissemination activity may not take place unless appropriate steps are taken to safeguard these legitimate interests. The beneficiaries may agree in writing on different time-limits to those set out in this paragraph, which may include a deadline for determining the appropriate steps to be taken, or may waive their right to prior notice for specific or all dissemination activities.
View SourceView Similar (7)
– Use and dissemination of foreground. 1. The beneficiaries shall use the foreground which they own or ensure that it is used. 2. Each beneficiary shall ensure that the foreground which it owns is disseminated as swiftly as possible. If it fails to do so, the Commission may disseminate that foreground. 3. Dissemination activities shall be compatible with the protection of intellectual property rights, confidentiality obligations and the legitimate interests of the owner(s) of the foreground. 9 The joint owners may agree not to continue with joint ownership but decide on an alternative regime (for example, a single owner with access rights for the other beneficiaries that transferred their ownership share). 4. At least 45 days prior notice of any dissemination activity shall be given to the other beneficiaries concerned, including sufficient information concerning the envisaged dissemination activity and the data to be disseminated. Following notification, any of those beneficiaries may object to the envisaged dissemination activity within 30 days of notification if it considers that its legitimate interests in relation to its foreground could suffer disproportionately great harm. In such cases, the dissemination activity may not take place unless appropriate steps are taken to safeguard these legitimate interests. The beneficiaries may agree in writing on different time-limits to those set out in this paragraph, which may include a deadline for determining the appropriate steps to be taken, or may waive their right to prior notice for specific or all dissemination activities.
View SourceView Similar (2)
– Use and dissemination of foreground. In addition to information in sections A and B below, the project partners would like to draw attention to OPSIC project’s roadmap to implementation of COMPASS into governmental end-users crisis management system. The road map is delivered as deliverable D7.
View Source
– Use and dissemination of foreground. 41 REPORT ON SOCIETAL IMPLICATIONS 58 FINAL REPORT ON THE DISTRIBUTION OF THE EUROPEAN UNION FINANCIAL CONTRIBUTION 65
View Source
– Use and dissemination of foreground. 12 2.1 SECTION A (PUBLIC) 12 2.1.1 List of scientific (peer reviewed) publications 12
View Source
– Use and dissemination of foreground. LOCAW has a coherent and consistent plan for the use and dissemination of foreground. Wide scientific dissemination of foreground is an important objective for LOCAW. Through the in- depth research that it has undertaken the LOCAW project has significantly advanced the knowledge-base on determinants of sustainable practices in organizations, as well as on the barriers of and drivers to transitions to sustainable organizations and communities. This is evidenced in two book chapters that have been published in recent volumes about green organisations; one of which focuses on how to encourage organisations to adopt sustainable policies (▇▇▇▇▇▇▇▇▇▇ & Steg, 2013), while the other provides a theoretical analysis of individual factors promoting pro-environmental actions in the workplace (▇▇▇▇▇▇▇ et al., in press). In addition, a first empirical paper on the results of the questionnaire studies conducted in the case study areas will be submitted to a peer reviewed international academic journal soon (▇▇▇▇▇▇▇ et al., forthcoming). A paper on the role of trade unions and global environmental change has already been published in a high-impact peer review journal (▇▇▇▇▇▇ & ▇▇▇▇▇▇▇, 2011). A high number of papers are planned to be prepared for the following few months, to be submitted to peer-reviewed journals: - one paper on adopting a sustainability approach to the study of organizations; - two papers on the simulation experiments testing several policy interventions; - one paper on the development of scenarios for transitions to future organizations using back-casting scenario development and testing assumptions through agent-based modelling; - a paper on the role of environmental self-identity and social networks in determining pro-environmental practices in the workplace; - several papers on sustainable practices in transnational corporations and crossing borders between work and home; - and a paper on testing causal models for predicting pro-environmental behaviour, to name the most important ones planned. - Besides these papers, to be submitted to peer-review journals, the Project Coordinator has established the first contacts with Routledge in order to submit a book proposal. The Consortium is now preparing the proposal for the book, which will be submitted to the publisher, who has already expressed interest in the dissemination of project results. Quite a high number of symposia were organized at international conferences and there are a few already submitted...
View Source
– Use and dissemination of foreground 
View SourceView Similar (3)

Related to – Use and dissemination of foreground

  • Specific Use and Disclosure Provisions (A) Except as otherwise limited in this Section of the Contract, Business Associate may use PHI for the proper management and administration of Business Associate or to carry out the legal responsibilities of Business Associate. (B) Except as otherwise limited in this Section of the Contract, Business Associate may disclose PHI for the proper management and administration of Business Associate, provided that disclosures are Required by Law, or Business Associate obtains reasonable assurances from the person to whom the information is disclosed that it will remain confidential and used or further disclosed only as Required by Law or for the purpose for which it was disclosed to the person, and the person notifies Business Associate of any instances of which it is aware in which the confidentiality of the information has been breached. (C) Except as otherwise limited in this Section of the Contract, Business Associate may use PHI to provide data aggregation services to Covered Entity as permitted by 45 C.F.R. § 164.504(e)(2)(i)(B).

  • Use and Disclosure All Confidential Information of a party will be held in confidence by the other party with at least the same degree of care as such party protects its own confidential or proprietary information of like kind and import, but not less than a reasonable degree of care. Neither party will disclose in any manner Confidential Information of the other party in any form to any person or entity without the other party’s prior consent. However, each party may disclose relevant aspects of the other party’s Confidential Information to its officers, affiliates, agents, subcontractors and employees to the extent reasonably necessary to perform its duties and obligations under this Agreement and such disclosure is not prohibited by applicable law. Without limiting the foregoing, each party will implement physical and other security measures and controls designed to protect (a) the security and confidentiality of Confidential Information; (b) against any threats or hazards to the security and integrity of Confidential Information; and (c) against any unauthorized access to or use of Confidential Information. To the extent that a party delegates any duties and responsibilities under this Agreement to an agent or other subcontractor, the party ensures that such agent and subcontractor are contractually bound to confidentiality terms consistent with the terms of this Section 11.

  • Permitted Uses and Disclosures of PHI and the third party notifies the Business Associate of any instances of which it is aware in which the confidentiality of the information has been breached.

  • Restrictions on Use and Disclosure Covered Entity shall notify Business Associate of any restriction on the use or disclosure of PHI that Covered Entity has agreed to in accordance with 45 C.F.R. § 164.522, to the extent such restriction may affect Business Associate’s use or disclosure of PHI.

  • Permitted Use and Disclosures Each Party hereto may use or disclose Confidential Information disclosed to it by the other Party to the extent such information is included in the Pharmacopeia Technology, Schering Technology or Collaboration Technology, as the case may be, and to the extent (i) such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder in filing or prosecuting patent applications, prosecuting or defending litigation, (ii) such disclosure is reasonably required to be made to any institutional review board of any entity conducting clinical trials with Agreement Compound(s) and/or Agreement Product(s), or to any governmental or other regulatory agency, in order to gain approval to conduct clinical trials or to market Agreement Compound(s) and/or Agreement Products, (iii) such disclosure is required by law, regulation, rule, act or order of any governmental authority, court, or agency, or is made in connection with submitting required information to tax or other governmental authorities, or (iv) such disclosure or use is reasonably required in conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted to it by the other Party pursuant to the terms of this Agreement; in each case, provided that if a Party is required to make any such disclosure of another Party’s Confidential Information, other than pursuant to a confidentiality agreement, it will give reasonable advance notice to the other Party of such disclosure and, save to the extent inappropriate in the case of patent applications, will use its reasonable diligent efforts to secure confidential treatment of such Confidential Information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.